Stay updated on Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial
Sign up to get notified when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.

Latest updates to the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page
- Check4 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5. This reflects a minor maintenance update to the page metadata.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a new revision version in the footer, updating from v3.6.3 to v3.6.4 to reflect a small update to the study page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing the previous v3.6.2 and indicating a new site release.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This reflects a behind-the-scenes update to the page's underlying template or metadata rather than a user-facing content change.SummaryDifference0.1%

- Check61 days agoChange DetectedRecruitment status on the study page now shows 'No longer looking for participants', indicating the study is no longer enrolling. The changes also add new help and navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and update the Intervention/Treatment label and revision footer to v3.6.0.SummaryDifference0.4%

- Check68 days agoChange DetectedThe page shows a minor revision update from v3.5.4 to v3.5.5. This indicates a small system update without changes to study content or user-facing information.SummaryDifference0.1%

Stay in the know with updates to Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.